Body mass index and glucose control play a role in the higher stillbirth risk for pregnant women with diabetes.  

Changes in hormones to help control normal blood glucose levels can lead to weight gain and possible heart disease in peoplw who skip breakfast.

The FDA rejected dapagliflozin as a treatment for type 1 diabetes although it was recently approved in Europe and Japan.

Men who have their glucose in control could be facing another challenge as a result.

Newborns could be fighting a tough, uphill battle as soon as they are born because of their mothers' weight.  

How does one year of intensive control compare to standard treatment?

Can lowering cholesterol be causing peripheral neuropathy?

We invite you to participate in exclusive research that will provide new insights into what you think about insulin pumps and daily injections. Whether you’re a patient, a patient family member, medical professional or diabetes educator, we need to hear from you.

Regular lifestyle counseling can have positive long term clinical outcomes in patients with diabetes.

Does your ancestral origin determine your risk of developing type 1 diabetes?